Post-Marathon Blood Work: Understanding Your Blood Test After a Marathon and When Results Return to Normal
Table of Contents
Introduction: Why Post-Marathon Blood Work Can Be Misleading
Many of my athletic patients are interested in blood tests. They tend to be highly aware of their bodies, and I often see that they want objective metrics to track different physiological parameters—much like they monitor their performance in training and competition.
However, I also frequently see athletes who have had blood tests shortly after a strenuous effort, such as a marathon, and are surprised by the results they receive.
What your blood work shows in the days after a marathon is not disease—it is physiology operating at its upper limits. Marathon running produces a predictable, time-limited cascade of blood marker changes that every athlete, coach, and treating clinician needs to understand. This is why post-marathon blood work is often misunderstood when the timing of the blood test after a marathon is not taken into account.
In this article, I outline which markers change after a marathon, when they peak, and—crucially—when they return to normal. My goal is to help you understand this timeline so you can avoid unnecessary panic, misguided treatment, and, perhaps most importantly, testing at the wrong time and drawing the wrong conclusions.
If you want a broader overview of which blood tests are actually worth running in the first place, I’ve covered that in my article Which Blood Tests Do Athletes Actually Need? A Doctor’s Evidence-Based Guide.
The Post-Marathon Inflammatory Cascade: What Is Actually Happening
Many patients think of inflammation as something inherently negative—I used to think the same. It was only during medical school that I first learned that inflammation is also a fundamental part of the body’s healing response. This is something I often explain to my patients.
For this reason, the physiological response after intense exercise closely resembles inflammation and even certain disease states—and in many ways, that is exactly the point.
Running 42.2 kilometres subjects the body to repetitive mechanical loading, sustained metabolic stress, elevated core temperature, and significant plasma volume shifts. The biological response is not a malfunction—it is a coordinated repair program. The problem arises when a clinician unfamiliar with exercise physiology sees the blood results and interprets normal post-race physiology as acute pathology [1].
The immediate post-race period produces what researchers describe as an acute phase response: a coordinated inflammatory signalling pattern involving cytokines, immune cell mobilization, and acute phase proteins. Studies of both marathon and half-marathon runners confirm that white blood cell counts, inflammatory markers, muscle damage enzymes, and iron storage proteins all rise significantly after racing, each following its own normalization timeline [2][8]. For athletes who want to understand how these same markers behave during training blocks—not just after racing—Endurance Athlete Blood Ranges: Why Standard Lab Values Miss Performance-Relevant Abnormalities provides useful context.
As a general rule, I tell my patients that lab abnormalities following exercise tend to resolve gradually over time, whereas pathological processes are more likely to persist or progress if left unaddressed. Understanding the timelines allows you to do two things: interpret existing results accurately, and schedule future testing strategically so that your blood work reflects your baseline biology rather than the aftermath of race day.
Marker-by-Marker: Timelines for Normalization
Creatine Kinase (CK): Days to Over a Week
Creatine kinase is the most dramatically elevated marker after a marathon, and the one most likely to trigger alarm bells when a non-sport-aware clinician sees the result. CK is released from skeletal muscle fibres when mechanical stress disrupts cell membrane integrity—it is, in essence, a leak marker for muscle damage [3].
In Boston Marathon runners tested 24 hours after the race, CK levels were significantly elevated across all participants, with faster finishers showing even higher values than slower runners—a counterintuitive finding explained by the greater pace-dependent eccentric loading in faster runners [3]. The standard upper limit of normal for CK in most laboratory reference ranges sits below 200 U/L. Post-marathon values routinely reach several hundred to several thousand U/L, with CK commonly peaking around 24–48 hours post-race.
An important clinical nuance is that enzyme patterns after a marathon can closely resemble those seen in pathology. An older review notes that plasma CK and related enzymes after a marathon may be indistinguishable from those seen in myocardial infarction and should therefore be interpreted with great caution in anyone who has exercised strenuously within the previous week [4]. This applies not only to total CK but also to CK-MB, which can rise to levels that mimic cardiac injury despite originating from skeletal muscle.
For this reason, modern clinical practice relies on cardiac troponin rather than CK-MB when myocardial injury is suspected. However, even troponin is not immune to this issue. Transient elevations have been documented in a significant proportion of marathon runners, typically peaking within hours of the finish and resolving within 24–72 hours [13]. Whether these rises reflect reversible membrane permeability changes or other mechanisms remains under investigation, but the key clinical message is clear: post-marathon troponin results must always be interpreted in the context of recent exertion, not in isolation.
In practice, everything comes back to clinical context. I only measure cardiac biomarkers when there is a genuine suspicion of cardiac pathology. If the patient has no symptoms or findings suggesting a cardiac cause, I do not see a reason to routinely test them.
Similarly, if I suspect rhabdomyolysis, I focus on total CK rather than CK-MB and would not routinely include troponin in that setting. This approach helps avoid unnecessary interpretative confusion, as well as downstream investigations and potentially avoidable hospital admissions.
Normalisation depends heavily on the individual runner, course profile, and race conditions. CK often begins declining after the 24–48 hour peak but may remain measurably elevated for anywhere from several days to 10–14 days in runners with greater muscle damage, significant downhill sections, or lower training status [3]. “Back to normal by day 7” is frequently too optimistic. For a detailed breakdown of what different CK levels mean in athletic populations—including when high values genuinely warrant concern—see Creatine Kinase Elevated in Athletes: Truths About High CK After a Workout. For practical purposes, a CK result obtained within two weeks of a marathon should be flagged as post-race and not used for clinical decision-making without context.
At the same time, CK is by no means an unnecessary test when there are symptoms suggestive of rhabdomyolysis—such as dark urine or unusually severe muscle pain. Rhabdomyolysis can sometimes present subtly and may catch even an experienced clinician off guard. I have seen cases where the symptoms were relatively mild—for example, a patient who developed pectoral muscle rhabdomyolysis after an intense CrossFit session.
In these situations, the evaluation should extend beyond CK alone. Urinalysis and markers such as myoglobin can help clarify the clinical picture and guide further management.
White Blood Cell Count (WBC): Hours to Several Days
Exercise-induced leukocytosis is one of the most consistent findings in marathon research. In a prospective study of non-professional marathon and half-marathon runners, WBC counts rose significantly at the finish line in both groups and returned to baseline after 2–7 days of recovery [2]. The peak occurs shortly post-race or within the first few hours afterward—catecholamine-driven demargination causes an acute rise, followed by a later cortisol-mediated neutrophil mobilisation that can sustain or amplify the count for several hours [5].
The post-marathon WBC picture is not homogeneous. While total white cell count and neutrophils rise substantially, lymphocytes characteristically fall [5]—a phenomenon commonly associated with the transient immunosuppression known as the “open window” effect, during which susceptibility to upper respiratory infection is temporarily increased [15]. Eosinophil counts also decrease after a marathon run, recovering gradually within the first 24 hours post-race [5]. For a full clinical breakdown of this pattern—including how to distinguish post-exercise leukocytosis from pathological causes—see High White Blood Cell Count After Exercise: When to Worry.
In an otherwise asymptomatic runner with a clear race history, a WBC of 12–15 × 10⁹/L within 24 hours of the finish is within the range of what exercise physiology studies describe, but clinical interpretation still requires consideration of the full picture—including symptoms, differential count, and fever. Most counts show significant improvement within 48–72 hours; the 2–7 day recovery window cited in marathon research reflects study sampling design and individual variability rather than a sharp normalization boundary [2].
Elevated white blood cell counts can, of course, be associated with infections and, more rarely, malignancy—which is understandably something that may worry patients.
In practice, however, this is usually a situation where it’s important to stay calm and interpret the results in context. I typically look at CRP alongside the white cell count and, most importantly, assess the patient’s clinical picture—are there any signs or symptoms suggesting infection?
In these situations, I usually repeat the labs and monitor both white blood cells and inflammatory markers over time to ensure they are trending down. It’s also worth noting that CRP may decline more slowly than the white blood cell count, so a short delay in normalization is not uncommon.
C-Reactive Protein (CRP): Peaks Around 24 Hours, Resolves Over Several Days
CRP is among the most dramatic responders to marathon running. The JACC systematic review on physical activity and inflammatory markers confirms that strenuous endurance exercise produces a marked but transient CRP rise as part of the acute phase response, with CRP commonly peaking around 24 hours after a race [6]. Studies in marathon cohorts found CRP increases of hundreds to over a thousand percent, with large inter-individual variability.
In a study specifically tracking CRP in recreational marathon runners before and for three days after the race, CRP peaked on day 1 post-race and remained elevated through day 3 [7]. For a deeper guide to how CRP behaves in athletic contexts across the training cycle—not just after racing—see Inflammation Markers in Athletes: CRP and Recovery.
An elevated CRP result in the immediate post-marathon window—even a markedly elevated one—does not indicate chronic inflammation or underlying inflammatory disease. It reflects the acute phase response to a known physiological stressor. Variability between individuals is high; some runners normalise within 48 hours while others remain above baseline for closer to a week. The practical implication is the same: do not interpret CRP drawn within the first week post-race as a meaningful resting inflammatory marker.
A note on liver enzymes: ASAT (aspartate aminotransferase) and ALAT (alanine aminotransferase) commonly rise after a marathon alongside CK, following a similar trajectory. Importantly, ASAT is found in skeletal muscle as well as the liver, and elevations after a marathon might be explained by exercise-induced muscle injury rather than primary hepatic pathology [14]. Elevated ASAT in a post-marathon blood panel might reflect muscle damage, not hepatic pathology, particularly when CK is also elevated. GGT, by contrast, is not present in muscle tissue and is a more specific indicator of liver involvement; a post-marathon picture of elevated ASAT and CK with normal GGT might argue against primary liver disease.
That said, in clinical practice I still recheck liver enzymes after recovery—typically after a couple of weeks—unless the patient has symptoms suggesting acute hepatic pathology, such as right upper quadrant pain, jaundice, or other concerning features. If enzyme levels remain elevated, I proceed stepwise: I usually start with ultrasound, and if needed, escalate to MRI based on clinical judgment. In most cases, by the time MRI is considered, I have already consulted the case with an internal medicine specialist.
After intense exercise, I often see CRP levels rise to values that can resemble those seen in bacterial infections. This is exactly where clinical judgment becomes essential.
In these situations, I always come back to the same question: does the patient actually have symptoms suggestive of infection—such as fever, cough, urinary symptoms, skin findings, or other systemic signs? If there are clear symptoms, I will usually extend the workup accordingly—this may include a chest X-ray, urine testing, and additional laboratory studies depending on the patient’s presentation.
At the same time, I generally do not check CRP after a strenuous exercise effort unless there is a clear clinical reason to do so. If the patient has no symptoms suggesting infection, I do not consider CRP particularly useful in that setting.
If symptoms are present, I keep the effect of recent exercise in mind—but I still aim to reasonably exclude an infectious cause and follow the clinical situation closely, with repeat assessments when needed.
Iron Markers and Ferritin: Weeks
Iron markers present the most clinically important timing challenge of all post-marathon blood markers. This is because the changes pull in different directions depending on which marker you are examining, and because a misinterpreted ferritin level can lead either to unnecessary iron supplementation or—more commonly—to false reassurance about iron stores that are actually depleted.
Serum ferritin rises acutely after a marathon as part of the acute phase response. In master runners tested before and at multiple timepoints after a 42.2 km race, significant ferritin elevations were observed at 1, 24, and 168 hours after the race in female runners, and at 24 and 168 hours in male runners [8]. This elevation does not reflect improved iron stores—it reflects ferritin’s role as an acute phase protein. When inflammatory signals are high, the liver upregulates ferritin production regardless of true iron status, creating a falsely elevated reading that masks the underlying picture [8].
In contrast to ferritin, serum iron typically falls in the acute post-race period as part of the inflammatory response. The standard acute-phase pattern seen in clinical medicine — ferritin up, serum iron down, transferrin saturation down — is the expected direction, though individual marker behaviour after ultraendurance events can deviate from this, as studies have observed variable changes in TIBC and transferrin saturation depending on race duration and timing of sampling [9]. This is precisely why a full iron panel drawn in the first days after a marathon needs to be read as a whole rather than any single marker taken at face value. For practical testing purposes, ferritin should not be used to assess iron status within at least two weeks—and ideally four weeks—of a marathon race. For a full guide to what ferritin levels actually mean for athletes, including the performance-relevant thresholds that general lab ranges miss, see Ferritin Levels for Athletes: Reasons Why “Normal” Isn’t Optimal. Female athletes should also consult Iron Panel Interpretation for Athletes: 7 Proven Insights Every Female Athlete Should Know and Female Athlete Bloodwork: A Complete Guide to Key Markers, Optimal Ranges, and Performance Implications for context on the particular iron challenges in this population.
For haemoglobin and haematocrit, the marathon produces a more nuanced picture. Research in marathon runners shows that haemoglobin and haematocrit can decline measurably in the first days after the race, reflecting both foot-strike haemolysis and plasma volume changes, with some studies finding these parameters still not fully normalised at 15 days [1]. Full haematological recovery should be expected to take approximately 1–3 weeks depending on the degree of haemolysis, hydration, and the runner’s iron status. For the mechanics of foot-strike red blood cell destruction specifically, see Footstrike Hemolysis in Distance Runners: Understanding the Mechanical Destruction of Red Blood Cells. For how haemoglobin changes in runners are interpreted clinically, see Hemoglobin Levels in Runners: When Low Is Normal vs. Performance-Limiting and Hematocrit in Athletes: What Your Blood Really Tells You About Performance.
Exercise-induced hepcidin typically rises during early recovery—studies show hepcidin commonly peaks around 3 hours post-endurance exercise—and can suppress iron absorption during that window. This has practical implications for supplementation timing: taking oral iron immediately after a hard session or race may result in reduced absorption, and spacing supplementation away from intense training is generally recommended. The relationship between serum iron and ferritin—and which one is the more reliable marker in any given clinical scenario—is covered in depth in Serum Iron vs Ferritin: Which Test Actually Matters for Athletes?
In general, I do not routinely check iron panels in athletes during periods of heavy training or competition. I usually prefer to wait until the competitive season has ended or the athlete is in a transition or off-season phase. This is typically the most appropriate time to assess iron status—when training load has been lower for several weeks and the results are more likely to reflect baseline physiology.
That said, the situation is different if the patient has clear symptoms suggestive of iron deficiency. In those cases, I do proceed with testing, but the results must be interpreted carefully, with a clear understanding of how recent training and competition can affect iron markers.
Ideally, these results should be reviewed by a physician familiar with sports physiology, as this context is essential for accurate interpretation.
Platelets: Variable, Generally 24–72 Hours
Platelet changes after a marathon are less dramatic than CK or CRP but clinically relevant because they occur alongside evidence of in vivo platelet activation. In a study of 32 healthy marathon runners, hematocrit and platelet count increased immediately post-race, consistent with haemoconcentration from dehydration, while mean platelet component—a measure of platelet granularity—decreased significantly (p < 0.0001), providing direct evidence of platelet activation during the race [10].
In a half-marathon study, platelet count and mean platelet volume (MPV) both increased significantly after the run, with values returning to baseline levels approximately 3 hours post-finish [11]. In ultra-marathon runners, platelet concentrations were elevated both immediately post-race and at nine days, with a transient decrease at day two—a pattern that may reflect platelet consumption followed by regenerative response [9]. For a complete guide to how platelets behave across the running and training cycle, see Platelet Count for Runners: Understanding Blood Test Changes in Marathon Training.
Mild post-marathon thrombocytosis (elevated platelet count) within the first 24–48 hours is generally consistent with normal physiology and reflects haemoconcentration and platelet activation rather than pathology. In contrast, more concerning findings—such as a markedly decreased platelet count or evidence of abnormal clotting—warrant further evaluation, as they would in any clinical context.
At the same time, I do not routinely check platelet counts—or even a full blood count—without a clear clinical indication. In practice, I order a full blood count, including platelets, when there is a specific reason to do so, such as suspected infection or bleeding.
Outside of these situations, I prefer to assess these markers at a more appropriate time—typically during a transition or off-season period—when training load has been lower and the results are more likely to reflect baseline physiology. If testing is required due to a suspected medical condition, I always take the timing of recent exercise into account and interpret the results accordingly.
Summary
Post-marathon blood work reflects a predictable physiological response rather than disease. Markers such as CK, white blood cells, CRP, liver enzymes, and ferritin often rise significantly after a race, each following its own timeline of normalization ranging from hours to several weeks. The key to correct interpretation is context: recent strenuous exercise can temporarily shift many laboratory values into ranges that would otherwise raise concern.
In my clinical practice, I emphasize two principles. First, most post-exercise abnormalities resolve gradually over time, whereas true pathological processes tend to persist or progress. Second, testing should be timed appropriately—ideally during periods of lower training load—so results reflect baseline physiology rather than acute recovery. When testing is required due to symptoms, results must be interpreted with an understanding of how exercise affects each marker.
Ultimately, the goal is not to avoid testing, but to use it intelligently. Understanding the expected post-marathon timeline allows athletes and clinicians to avoid unnecessary alarm, reduce inappropriate investigations, and focus attention on findings that truly warrant further evaluation.
References
- https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2019.00697/full
- https://www.nature.com/articles/srep32315
- https://pmc.ncbi.nlm.nih.gov/articles/PMC2595821/
- https://pubmed.ncbi.nlm.nih.gov/6525495/
- https://pubmed.ncbi.nlm.nih.gov/19196379/
- https://www.jacc.org/doi/10.1016/j.jacc.2004.12.077
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6267712/
- https://pubmed.ncbi.nlm.nih.gov/3804618/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4572198/
- https://pubmed.ncbi.nlm.nih.gov/16393676/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4147199/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5640004/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8663527/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4415847/
- https://pubmed.ncbi.nlm.nih.gov/20839496/
